Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through

Tayebe Ramezani1, Mohamad Nabiuni1, Javad Baharara2

  • 1Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

Insights

Curcumin-coated silver nanoparticles (cAgNPs) combined with cisplatin restore sensitivity in drug-resistant ovarian cancer cells. This synergistic approach enhances apoptosis and upregulates p53, offering a promising strategy against cisplatin resistance.

Area of Science:

  • Nanomedicine
  • Cancer Therapeutics
  • Drug Resistance

Background:

  • Drug resistance is a major challenge in cancer treatment, necessitating novel therapeutic strategies.
  • Silver nanoparticles (AgNPs) exhibit anticancer properties and are explored for combination therapies.
  • Curcumin-coated silver nanoparticles (cAgNPs) offer potential synergistic effects with conventional chemotherapeutics.

Purpose of the Study:

  • To investigate the synergistic effects of biogenic curcumin-coated silver nanoparticles (cAgNPs) and cisplatin on cisplatin-resistant ovarian cancer cells (A2780).
  • To evaluate the ability of cAgNPs to restore sensitivity to cisplatin in resistant ovarian cancer models.
  • To assess the impact of combined therapy on apoptosis induction and gene expression.

Main Methods:

  • Cell viability was assessed using MTT assay.
  • Apoptosis was evaluated through Acridine orange/propidium iodide (AO/PI), DAPI staining, and Annexin V/PI assays.
  • Caspase 3/9 activation and gene expression (p53, MMP-9) via RT-PCR were analyzed.

Main Results:

  • Combined treatment with non-toxic concentrations of cAgNPs (2 µg/mL) and cisplatin (2.5 µg/mL) reduced proliferation by approximately 50%.
  • Synergistic use significantly increased apoptosis induction, as evidenced by AO/PI, DAPI, and Annexin V/PI assays.
  • Combined therapy led to increased caspase 3/9 activity, upregulated p53 expression, and downregulated MMP-9 expression.

Conclusions:

  • Combination of cAgNPs and cisplatin effectively overcomes cisplatin resistance in ovarian cancer cells.
  • The synergistic approach enhances apoptosis through caspase activation and modulation of p53 and MMP-9.
  • This combination therapy presents a promising strategy to improve treatment outcomes for cisplatin-resistant ovarian cancer.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.6K
Resistance and Conductance01:25

Resistance and Conductance

A conductor's DC resistance at a given temperature is influenced by its resistivity, length, and cross-sectional area. Resistivity is an inherent property of the conductor material, with annealed copper serving as the international standard for measurement. For instance, the resistivity of hard-drawn aluminum at 20 degrees Celsius is 61% of the standard conductivity of annealed copper.
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
499
Equivalent Resistance01:16

Equivalent Resistance

In circuit analysis, situations often arise where resistors are neither in series nor parallel configurations. To tackle such scenarios, three-terminal equivalent networks like the wye (Y) (Figure 1 (a)) or tee (T) and delta (Δ) (Figure 1 (b)) or pi (π) networks come into play. These networks offer versatile solutions and are frequently encountered in various applications, including three-phase electrical systems, electrical filters, and matching networks.
948